Literature DB >> 29159756

Patient-Provider Communication and Health Outcomes Among Individuals with Hepato-Pancreato-Biliary Disease in the USA.

Qinyu Chen1, Eliza W Beal1, Eric B Schneider1, Victor Okunrintemi2, Xu-Feng Zhang1,3, Timothy M Pawlik4.   

Abstract

BACKGROUND: Patient-provider communication (PPC) is utilized as a value-based metric in pay-for-performance programs. We sought to evaluate the association of PPC with patient-reported health outcomes, as well as healthcare resource utilization among a nationally representative cohort of patients with hepato-pancreato-biliary (HPB) diagnoses.
METHODS: Patients with HPB diseases were identified from the 2008-2014 Medical Expenditure Panel Survey cohort. A weighted PPC composite score was categorized using the responses from the CAHPS (Consumer Assessment of Healthcare Providers and Systems) survey as optimal, average, or poor. Multivariate analysis was performed using logistic regression.
RESULTS: Among 1951 adult-patients, representing 21.7 million HPB patients, reported PPC was optimal (33.4%), average (46.3%), or poor (15.3%). Patients who were older and patients with low income were more likely to report poor PPC (both p < 0.05). Statin use, a quality of care measure, was associated with optimal PPC (OR 1.70, 95% CI 1.10-2.64; p = 0.01). In contrast, patients who reported poor PPC were more likely to have a poor physical (20.8%) or mental (8.8%) health component on their SF12 (both p < 0.05). Furthermore, patients with poor PPC were more likely to report poor mental status (OR 2.97, 95% CI 1.60-5.52), as well as higher emergency department visits (OR 1.95, 95% CI 1.25-3.05) and hospitalizations (OR 1.90, 95% CI 1.02-3.55) (both p < 0.05). Reported PPC was not associated with differences in overall healthcare expenditures or out-of-pocket expenditures.
CONCLUSIONS: PPC was associated with a wide spectrum of patient-specific demographic and health utilization factors. Self-reported patient satisfaction with provider communication may be impacted by other considerations than simply the patient-provider interaction.

Entities:  

Keywords:  HPB disease; Health outcomes; Hospital utilization; Patient-provider communication; Quality of care measures

Mesh:

Year:  2017        PMID: 29159756     DOI: 10.1007/s11605-017-3610-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  5 in total

1.  Impact of Post-Discharge Disposition on Risk and Causes of Readmission Following Liver and Pancreas Surgery.

Authors:  Qinyu Chen; Katiuscha Merath; Griffin Olsen; Fabio Bagante; Jay J Idrees; Ozgur Akgul; Jordan Cloyd; Carl Schmidt; Mary Dillhoff; Eliza W Beal; Susan White; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-03-22       Impact factor: 3.452

2.  Racial/ethnic disparities in patient experiences with care and Gleason score at diagnosis of prostate cancer: a SEER-CAHPS study.

Authors:  Stephanie Navarro; Xiaohui Hu; Aaron Mejia; Carol Y Ochoa; Trevor A Pickering; Leslie Ballas; Albert J Farias
Journal:  Cancer Causes Control       Date:  2022-01-15       Impact factor: 2.506

3.  General Health Care Utilization Among Nonelderly Cancer Survivors Before and After Affordable Care Act Implementation: Early Results.

Authors:  Amy L Shaver; Ying Cao; Katia Noyes
Journal:  JCO Oncol Pract       Date:  2020-02-18

4.  Validation of a patient-reported measure of social support provided by nurses in breast cancer care (SuPP-N): based on a cross-sectional patient survey in 83 German hospitals.

Authors:  Johanna Sophie Lubasch; Susan Lee; Markus Antonius Wirtz; Holger Pfaff; Lena Ansmann
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

5.  Age-specific differences in patient reported outcomes among adults with atherosclerotic cardiovascular disease: Medical expenditure panel survey 2006-2015.

Authors:  Victor Okunrintemi; Eve-Marie A Benson; Ouassim Derbal; Michael D Miedema; Roger S Blumenthal; Martin Tibuakuu; Oluseye Ogunmoroti; Safi U Khan; Mamas A Mamas; Martha Gulati; Erin D Michos
Journal:  Am J Prev Cardiol       Date:  2020-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.